Jul 11, 2017Gene Therapy for Usher SyndromePress Release: ProQR gets FDA orphan status designation for it's investigational drug QRX-411 for Usher Syndrome. Drug shows promise in pre-clinical studies. Read more from AAO.org #genetherapy #ushersyndrome
Press Release: ProQR gets FDA orphan status designation for it's investigational drug QRX-411 for Usher Syndrome. Drug shows promise in pre-clinical studies. Read more from AAO.org #genetherapy #ushersyndrome